Research Square · Aug 28, 2026
Paternal Origin and Subsequent Maternal Inheritance of a Novel FOXL2 Frameshift Variant Underlie Accelerated Ovarian Aging: A Three-Generation BPES-I Family Study
By Li S, Hu M, Xu R et al.
Background : Type I Blepharophimosis-Ptosis-Epicanthus Inversus Syndrome (BPES-I) is characterized by eyelid malformations and Premature Ovarian Insufficiency (POI). While FOXL2 variants are the primary cause, the impact of paternal origin followed by maternal inheritance on ovarian aging trajectories remains poorly defined. This study characterizes a three-generation Chinese family with a novel FOXL2 variant to elucidate its structural consequences and impact on the ovarian reserve trajectory. Methods : Comprehensive clinical and hormonal assessments were performed. Whole Exome Sequencing (WES) and Sanger sequencing identified the causal variant, which was classified using ACMG 2015 guidelines and structurally mapped via AlphaFold3. Wild-type and mutant plasmids were transfected into HeLa cells to assess mRNA/protein expression via RT-qPCR and Western blotting. Downstream targets were validated by RT-qPCR. Results : A novel heterozygous FOXL2 frameshift variant, c.962_967delinsCT (p.Gln321Profs*34), was identified and classified as Pathogenic (De Baere Class D). Segregation analysis revealed the variant originated from the maternal grandfather (paternal origin) and was subsequently transmitted maternally to the mother, aunt, and proband. Functionally, the mutant exhibited significant mRNA and protein decay, confirming haploinsufficiency. Clinically, the family exhibited a striking acceleration of the ovarian aging trajectory: the mother and the aunt experienced fertility and early menopause at 40-41 years, whereas the proband presented with infertility and severe POI at 26 years. This anticipation-like pattern highlights the dosage-sensitive nature of FOXL2 in maintaining the primordial follicle pool. The mutant protein failed to sustain the expression of key folliculogenesis regulators, including CYP19A1 and FST . Conclusion : We firstly report a paternally derived FOXL2 variant can drive severe BPES-I via maternal inheritance. The convergence of clinical phenotyping, wet-lab validation, and public bioinformatics data establishes a robust model of FOXL2 -driven accelerated ovarian aging, advocating for universal AMH surveillance in female carriers regardless of variant origin.